OMGA Omega Therapeutics Corp: Bozor kapitallashuvining balans qiymatiga nisbati

Omega Therapeutics (OMGA) kompaniyasining rasmiy ramzlari

Omega Therapeutics jigar saratoni terapiyasi xavfsizligiga e'tibor qaratgan holda, genlar ekspressiyasini boshqarish uchun OMEGA platformasini ishlab chiqmoqda. Biroq, xalqaro beqarorlik va sanksiyalar biomateriallar logistikasini murakkablashtirib, DNKga asoslangan dori vositalarini yaratishga to'sqinlik qilmoqda. Yuqori ilmiy nufuz va hamkorlarning ishonchi aksiyadorlar sodiqligini ta'minlamoqda. Buxgalteriya qiymatiga nisbatan narx koeffitsiyenti dinamikasi joriy tendentsiyani aks ettirmoqda, bunda qiymat 0.65 darajasida mustahkamlandi.

Omega Therapeutics Corp (OMGA): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 08.03.2025gacha

Omega Therapeutics Inc (OMGA) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Omega Therapeutics|OMGA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Omega|OMGA - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Omega Therapeutics|OMGA - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati omegatherapeutics.com|OMGA - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Omega Therapeutics|OMGA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Omega|OMGA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Omega
Kompaniyaning dastlabki tahlili:Omega Therapeutics
Omega brendining mahsuloti

Ushbu koeffitsiyent pul oqimlari prizmasi orqali bozor qiymatining moddiy aktivlarga sezgirligini aks ettiradi. U bozor kapitalizatsiyasini sof kapital bilan solishtirib, biznesning haddan tashqari yuqori yoki past baholangan davrlarini aniqlaydi. Omega Therapeutics (OMGA) uchun ushbu farq uning epigenetik platformasining muvaffaqiyatiga va klinik sinovlarning xavfsizligiga bog'liq. Bozor kapitalizatsiyasi va balans qiymati o'rtasidagi tarixiy bog'liqlikni tahlil qilish kompaniyaning investitsiya jozibadorligini aniqlash imkonini beradi.

Raqobatchilar tahlili

TEM: Bozor kapitallashuvining balans qiymatiga nisbati|qiagen.com (QGEN) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|ultragenyx.com - Bozor kapitallashuvining balans qiymatiga nisbati|BEAM (Beam Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|SRPT: Bozor qiymatining balans qiymatiga koeffitsiyenti|TWST (Twist Bio) - Bozor qiymatining balans qiymatiga nisbati|10x (TXG) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati NTLA (Intellia Therapeutics)|Bozor qiymatining balans qiymatiga koeffitsiyenti stoketherapeutics.com|BLFS: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Wave Life Sciences Ltd (WVE)|Bozor kapitallashuvining balans qiymatiga nisbati MAZE (Maze Tx)|SION - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Prime Medicine, Inc. (PRME)|tayshagtx.com (TSHA) - Balans qiymatiga nisbatan bozor qiymati|QURE - Kapitallashuvning sof aktivlarga nisbati|MeiraGTx Holdings (MGTX) - Bozor kapitallashuvining balans qiymatiga multiplikatori|RGNX - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Solid Corp|Ocugen, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti PACB (pacb.com)|Bozor qiymatining balans qiymatiga nisbati Benitec Biopharma|Balans qiymatiga nisbatan bozor qiymati Design Therapeutics Inc DSGN|Rocket Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|FDMT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati lexeotx.com (LXEO)|Korro Bio (KRRO) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati EDIT (Editas Medicine)|Bozor qiymatining balans qiymatiga koeffitsiyenti Silence Therapeutics PLC (SLN)|Kapitallashuvning sof aktivlarga nisbati PRQR|Bozor kapitallashuvining balans qiymatiga nisbati codexis.com CDXS|Kapitallashuvning sof aktivlarga nisbati Sangamo Therapeutics (SGMO)|Bozor kapitallashuvining balans qiymatiga multiplikatori Nautilus Biotechnology, Inc. NAUT|Bozor kapitallashuvining balans qiymatiga nisbati MGX (Metagenomi)|DTIL - Balans qiymatiga nisbatan bozor kapitallashuvi|GBIO (generationbio.com) - Bozor kapitallashuvining balans qiymatiga nisbati|BOLD (Boundless Bio Inc) - Kapitallashuvning sof aktivlarga nisbati|XCUR: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IMNN|Phio Pharmaceuticals - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti MBIO (mustangbio.com)|TransCode Therapeutics, Inc. - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Bionano Genomics Inc. BNGO|Bozor kapitallashuvining balans qiymatiga nisbati APDN|BLUE - Bozor qiymatining xususiy kapitalga nisbati|IPA: Bozor kapitallashuvining balans qiymatiga nisbati|Singular Genomics Systems, Inc. (OMIC) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Regulus Therapeutics Inc (RGLS)|Kapitallashuvning balans qiymatiga nisbati SYRS|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. TBIO|Kapitallashuvning balans qiymatiga nisbati traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)